Log In
Print this Print this

Razadyne, galantamine (formerly Reminyl)

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionAcetylcholinesterase (AChE) inhibitor and nicotinic receptor modulator
Molecular Target Acetylcholinesterase (AChE) ; Nicotinic receptor
Mechanism of ActionAcetylcholinesterase (AChE) inhibitor; Nicotinic receptor modulator
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD); Treat Alzheimer's disease (AD) in patients with mild cognitive impairment (MCI); Treat dementia in cerebrovascular disease patients; Treat mild to moderate Alzheimer's disease (AD)
Regulatory Designation
PartnerJohnson & Johnson;
Takeda Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today